Gene-promoter hypermethylation as a biomarker in lung cancer
- PMID: 15343277
- DOI: 10.1038/nrc1432
Gene-promoter hypermethylation as a biomarker in lung cancer
Abstract
Silencing of genes by aberrant promoter hypermethylation is now recognized as a crucial component in cancer initiation and progression. Highly sensitive assays have been developed to assess gene-promoter methylation in biological fluids. The detection of methylated genes in sputum could lead to the development of a screening test to non-invasively identify early cancer in high-risk people.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
